====================
Monday, October 19, 2020
1:00 PM - 2:30 PM
(W7) AMCP Talks: Future Trends in Health Technology and Digital Therapeutics
Susan Bratton, BA, MBA; Kelsey Moss, PharmD; Alif Saleh; Kerri Petrin, MPH; David Veenstra, PharmD, PhD; Joseph Honcz, RPh MBA
====================
Monday, October 19, 2020
3:00 PM - 4:30 PM
(H1) Practical Applications to Close Gender and Diversity Gaps in Health Care Leadership
Deanna L. Banks; Kristi Bochniak, RN, MSN, MBA, CPHQ; Mona Chitre, PharmD; Sharon M. Montgomery, BS Pharm, MA; Norrie Thomas, RPh, MS, PhD; Diane Giaquinta, PharmD, FAMCP
====================
Tuesday, October 20, 2020
3:00 PM - 4:00 PM
(W1) A Gene-normous Leap in Modern Medicine

Timothy Chiu, PharmD, BCPS; Jennifer M. Day, PharmD
====================
Tuesday, October 20, 2020
3:00 PM - 4:00 PM
(L1) Federal and State Legislative and Regulatory Update

Stephen Northrup, MPA; Daniel Tomaszewski
====================
Tuesday, October 20, 2020
3:00 PM - 4:00 PM
(W2) AMCP Partner Session: Case Studies of How Prescription Digital Therapeutics Help Payers Achieve the Quadruple Aim
Katie Archer; Yuri Maricich, MD; Michael Pace; Fulton Velez, MD, MS, MBA; Renee Wallace
====================
Tuesday, October 20, 2020
4:30 PM - 5:30 PM
(W3) The Evolving Role of Managed Care in the Gene Therapy Era: Focus on Hemophilia

Rebecca L. Bigler, PhD; Molly Borchardt, PharmD
====================
Tuesday, October 20, 2020
4:30 PM - 5:30 PM
(D3) Visualizing and Preparing for Future of MS Treatments

Folayemi Fashola, PharmD, BCACP, MSCS; Shilpa Klocke, PharmD, BCPS
====================
Tuesday, October 20, 2020
4:30 PM - 5:30 PM
(M5) Managing Different Perspectives: Panel Discussion on Integrating Medical and Pharmacy Benefits

Susan L. Downard, RPh; Christina Link, PharmD; Mitchel J. Seleznick, MD, MPH
====================
Tuesday, October 20, 2020
4:30 PM - 5:30 PM
(L5) Scope of Practice for Managed Care Pharmacists in a Post-COVID-19 World

Nick Diamond; Daniel Nam; Margaret Scott, MS, MPH, RPh
====================
Wednesday, October 21, 2020
11:00 AM - 12:00 PM
(M1) The Present and Future of Specialty Drug Management Strategies

Eric Cannon, PharmD, FAMCP; Dino Conti, PharmD, MBA; Babette S. Edgar, PharmD, MBA, FAMCP; Tasmiya Khan, PharmD
====================
Wednesday, October 21, 2020
11:00 AM - 12:00 PM
(R2) How is Real-World Evidence in Oncology Used by Payers in Decision-Making?

Christina Barrington, PharmD; Diana Brixner, RPh, PhD; Daniel Malone, RPh, PhD, FAMCP
====================
Wednesday, October 21, 2020
11:00 AM - 12:00 PM
(M4) Impact of Direct Negotiation and Value-Based Contracting Authorities in a Medicaid Program

Paul L. Jeffrey, PharmD; Kimberly Lenz, PharmD
====================
Wednesday, October 21, 2020
2:30 PM - 3:30 PM
(R3) Funding versus Innovation: Pharmacist Engagement with Patient-Reported Outcomes

Ann Fish-Steagall, RN,OCN; Chester B. Good, MD, MPH; Theresa L. Schmidt, MA, PMP, CSPO
====================
Wednesday, October 21, 2020
2:30 PM - 3:30 PM
(L3) Managed Medicaid Update: Annual Drug Use Review Results

John M. Coster, BS, MPS, PhD; Jim Hopsicker, RPh, MBA; Paul L. Jeffrey, PharmD
====================
Wednesday, October 21, 2020
2:30 PM - 3:30 PM
(D5) Updates in Oncology: Ghosts of Past, Present, and Future

Timothy Chiu, PharmD, BCPS; Stephanie L. Ho, PharmD, BCPS
====================
Wednesday, October 21, 2020
2:30 PM - 3:30 PM
(M6) Value-Based Payment Models: Opportunities to Integrate Pharmacists from a Variety of Practice Settings

Joseph A. Albright, PharmD; Brenden O'Hara, RPh, BCACP
====================
Wednesday, October 21, 2020
4:00 PM - 5:00 PM
(R1) Get to the Point: A Managed Care Pharmacy Research Podium Session

James P. Burke, PhD; Justin Gatwood, PhD; Christopher V. Quenelle, PharmD; Benjamin Y. Urick, PharmD, PhD; Karen L. Rascati, PhD
====================
Wednesday, October 21, 2020
4:00 PM - 5:00 PM
(D1) Overcoming Barriers to Biosimilar Adoption through Coordinated Efforts

Matthew Moser, PharmD, CPh; Jay D. Pauly, PharmD, BCPS, CPh; Gene Terkoski, PharmD
====================
Wednesday, October 21, 2020
4:00 PM - 5:00 PM
(W6) White and Brown-Bagging: Emerging Practice, Legislative and Board of Pharmacy Trends

Evangelina Berrios Colon, PharmD, MPH; Mary Choy, PharmD, BCGP, FASHP; Martha M. Rumore, PharmD, JD, LLM, FAPhA
====================
Thursday, October 22, 2020
11:00 AM - 12:00 PM
(D2) Keeping Up with Rare Disease Therapies: Pipeline to Management Solutions Track

YuQian Liu, PharmD; Brian MacDonald, PharmD
====================
Thursday, October 22, 2020
11:00 AM - 12:00 PM
(L4) Keeping Up with State Legislators: Legislative Updates and Outlook

Timothy J. Antonelli, BSPharmacy, RPh; Manjula D. Jayabalan, PharmD, MBA; Lisa C. Le Gette, RPh, MBA
====================
Thursday, October 22, 2020
11:00 AM - 12:00 PM
(SP1) Introduction to Digital Therapeutics: What You Need to Know
Megan Coder, PharmD, MBA
====================
Thursday, October 22, 2020
2:30 PM - 3:30 PM
(L2) The State of Prescription Drug Pricing Reform: Are States Leading the Way for the US?

Melissa Andel, MPP
====================
Thursday, October 22, 2020
2:30 PM - 3:30 PM
(M3) Impact of Prescription Drug Reference Pricing on Drug Spend and Utilization

Christopher Whaley; Richard Zabinski, PharmD, FAMCP
====================
Thursday, October 22, 2020
2:30 PM - 3:30 PM
(R6) Developing Successful Actuary and Pharmacy Team Partnerships

Nicole Bulochnik, MS, PharmD, BCPS, BCCCP, CRC; Karl J. Gregor, PharmD, MS; Whitney S. Pratt, FSA, CERA, MAAA; Susan Silseth, FSA, MAAA
====================
Thursday, October 22, 2020
2:30 PM - 3:30 PM
(SP2) Career Pathways in Managed Care Pharmacy
Maher Abdel-Sattar, PharmD, MS; Kheelan Gopal, PharmD; Sarah Hulvershorn, PharmD, MS, BCPS; Steven Kheloussi, PharmD, MBA; Joey Pippin, PharmD
====================
Friday, October 23, 2020
11:00 AM - 12:00 PM
(R4) Population Management: Zooming in on Rare Diseases with ICER Reports

Steven Pearson, MD, MSc; Emily G. Tsiao, PharmD; John B. Watkins, PharmD, MPH, BCPS
====================
Friday, October 23, 2020
11:00 AM - 12:00 PM
(D4) Preparing for the Future of Duchenne Muscular Dystrophy Precision Therapy

Rebecca L. Bigler, PhD; Molly Borchardt, PharmD
====================
Friday, October 23, 2020
11:00 AM - 12:00 PM
(W5) Cell and Gene Therapy Payment Models: Balancing Access to Innovation, Cost and Affordability

Brian Corvino, MBA, Wharton (University of Pennsylvania); Jennifer Sturm, MBA
====================
Friday, October 23, 2020
1:30 PM - 2:45 PM
(P1) Specialty Pharmaceuticals in Development

Aimee Tharaldson, PharmD